Therapy News and Research

RSS

Longer treatment with antiretroviral Nevirapine reduces risk of HIV among infants

Extended treatment with the antiretroviral drug nevirapine in conjunction with the standard therapy might reduce the risk of mother-to-child HIV transmission, according to a study published Wednesday in the New England Journal of Medicine, Reuters reports (Emery, Reuters, 6/4).

8 Jun 2008

Speakers at second HIV/AIDS implementers' meeting in Uganda call for increased HIV prevention efforts

Conference delegates on Tuesday at the opening of the 2008 HIV/AIDS Implementers' Meeting in Kampala, Uganda, called on countries to increase HIV prevention methods in order to fight complacency about the disease, Xinhuanet reports. Some HIV/AIDS experts speaking at the conference said that although countries have started recording lower HIV/AIDS rates, most responses do not pay enough attention to prevention.

8 Jun 2008

Rochester probes drug therapy, parent training for kids with both autism, ADHD

A National Institutes of Health grant awarded earlier today will empower a team of University of Rochester investigators studying if a blend of drug and behavioral therapy can bring relief to the nearly one-fourth of children with autism who also live with symptoms of ADHD, or attention deficit hyperactivity disorder.

5 Jun 2008

Majority of U.S. House supports repeal of Medicare therapy caps

With about one month to go before the current exceptions process for clinically based care above the Medicare therapy caps expires, a majority of the U.S. House of Representatives has endorsed legislation to repeal the arbitrary financial limit on therapy benefits.

5 Jun 2008

New perspective on coronary disease thanks to ultrasound

Compared to other techniques, Intravascular Ultrasound (IVUS) is much better at monitoring the increase or decrease of atherosclerosis in the coronary arteries. Can the method even be used to predict the odds of a heart attack or other cardiovascular event? Studies indicate this may be the case, states Professor Clemens von Birgelen in his inaugural address at the University of Twente.

5 Jun 2008

Role of breastfeeding in preventing infant death, HIV infection in developing countries

In many poor countries, mothers with HIV face a stark choice: to nurse their infants, and risk passing on HIV through their breast milk - or to formula feed, and deprive their infants of much of the natural immunity needed to protect against fatal diseases of early infancy. Now, two studies supported by the National Institutes of Health offer insights into preventing early death and HIV infection among breastfeeding infants of mothers with HIV in these countries.

5 Jun 2008

Prostate Cancer Foundation 'beefs up' cancer research

The Prostate Cancer Foundation (PCF) has committed more than $19 million in new research funding for scientific investigations focused on discovering new treatments for recurrent prostate cancer. A total of eight programs representing 18 leading research institutions and 36 researchers were selected as part of the foundation's 2008 Challenge Awards. The funded programs will receive the first of three annual payments, ranging between $500,000 and $1.0 million per program, this week.

4 Jun 2008

Single drug treatment a viable option to radiation for early testicular cancer

The results of research into early testicular cancer has found that a single chemotherapy treatment is just as effective as radiation therapy while much less toxic.

4 Jun 2008

New molecular mechanism for colorectal cancer

Scientists in Portugal just found a new molecular mechanism behind colorectal cancer in which a mutated and a normal, but over-expressed, gene cooperate and are both needed to create the disease.

4 Jun 2008

Hair cloning technique may be cure for baldness

The ability of scientists to clone hair cells in a laboratory means premature baldness could soon be a thing of the past.

3 Jun 2008

Incidence of melanoma and other malignancies among rheumatoid arthritis patients treated with Methotrexate

A chronic, inflammatory disease of unknown origin, rheumatoid arthritis (RA) affects about 1 percent of adults worldwide. Marked by joint destruction, RA often leads to disability and diminished quality of life. It can also lead to an early death from cancer.

3 Jun 2008

U of M sets new standard of care for recessive dystrophic epidermolysis bullosa

Physicians at the University of Minnesota and University of Minnesota Children's Hospital, Fairview have set the path to a cure for a young boy's fatal genetic skin disease, recessive dystrophic epidermolysis bullosa (RDEB), by using a cord blood and bone marrow transplant. Nate Liao, a 25-month-old from Clarksburg, N.J., underwent the experimental therapy in October 2007.

3 Jun 2008

Cephalon files patent infringement case against Watson Pharmaceuticals

Cephalon, Inc. today announced that it and its wholly-owned subsidiary CIMA LABS INC. have filed a lawsuit in U.S. District Court in Delaware against Watson Pharmaceuticals, Inc. and its wholly-owned subsidiary, Watson Laboratories, Inc., for infringement of U.S. Patent Nos. 6,200,604 and 6,974,590, which cover methods of use for the Cephalon product FENTORA(R) (fentanyl buccal tablet) [C-II].

3 Jun 2008

Silver rings to alleviate symptoms of arthritis

Research by academics at the University of Southampton in collaboration with occupational therapy clinicians into the effectiveness of wearing a particular type of silver ring to alleviate symptoms of arthritis has won an award.

3 Jun 2008

Writing techniques improve results of post-traumatic therapy

Writing as a component of a clinical course of therapy improves results and allows patients to recover more quickly. Doctoral candidate Peggy Penn concludes this in her thesis, which she defended on Monday June 2nd at Tilburg University in the Netherlands.

3 Jun 2008

Paclitaxel Poliglumex/Capecitabine regimen well tolerated and active in metastatic breast cancer

At the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO), data were presented from a phase II investigator-sponsored trial paclitaxel poliglumex (Opaxio, CT-2103) in combination with capecitabine in first-line treatment of patients with metastatic breast cancer (MBC).

3 Jun 2008

By 2024 one in seven women will be diagnosed with breast cancer

Experts in Britain are predicting that by 2024 one in seven women will be diagnosed with breast cancer if there is not an improvement in public health trends.

2 Jun 2008

Cetuximab and chemotherapy combination proves safe, effective for head and neck cancer patients

Patients treated for locally advanced head and neck cancer may respond better to treatment with the addition of cetuximab to chemotherapy, according to a University of Pittsburgh Cancer Institute (UPCI) phase II study. The results will be presented at the 44th annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago as an oral presentation.

2 Jun 2008

Less than 1 in 5 patients receive treatment to prevent venous thrombosis after surgery

Fewer than 1 in 5 patients received post-discharge therapy to prevent life-threatening blood clots - venous thrombosis - after hip- or knee-replacement surgery, report Rahme and colleagues in a retrospective cohort study. Venous thrombosis is one of the leading causes of death among hospital patients. However, elderly patients have a 70% lower chance of dying within 3 months if they take an anticoagulant drug to prevent blood clots.

2 Jun 2008

Exposure-based therapy may help prevent post-traumatic stress disorder

Exposure-based therapy, in which recent trauma survivors are instructed to relive the troubling event, may be effective in preventing the progression from acute stress disorder to post-traumatic stress disorder, according to a report in the June issue of Archives of General Psychiatry.

2 Jun 2008

Therapy News and Research

Longer treatment with antiretroviral Nevirapine reduces risk of HIV among infants

Speakers at second HIV/AIDS implementers' meeting in Uganda call for increased HIV prevention efforts

Rochester probes drug therapy, parent training for kids with both autism, ADHD

Majority of U.S. House supports repeal of Medicare therapy caps

New perspective on coronary disease thanks to ultrasound

Role of breastfeeding in preventing infant death, HIV infection in developing countries

Prostate Cancer Foundation 'beefs up' cancer research

Single drug treatment a viable option to radiation for early testicular cancer

New molecular mechanism for colorectal cancer

Hair cloning technique may be cure for baldness

Incidence of melanoma and other malignancies among rheumatoid arthritis patients treated with Methotrexate

U of M sets new standard of care for recessive dystrophic epidermolysis bullosa

Cephalon files patent infringement case against Watson Pharmaceuticals

Silver rings to alleviate symptoms of arthritis

Writing techniques improve results of post-traumatic therapy

Paclitaxel Poliglumex/Capecitabine regimen well tolerated and active in metastatic breast cancer

By 2024 one in seven women will be diagnosed with breast cancer

Cetuximab and chemotherapy combination proves safe, effective for head and neck cancer patients

Less than 1 in 5 patients receive treatment to prevent venous thrombosis after surgery

Exposure-based therapy may help prevent post-traumatic stress disorder

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News